Kenvue

Kenvue is the world's largest pure-play consumer health company by revenue, spun off from Johnson & Johnson in 2023. Built on more than 135 years of heritage across its portfolio of trusted brands—including Neutrogena, Aveeno, BAND-AID, Tylenol, Listerine, OGX, and Zyrtec—Kenvue combines deep consumer insights with rigorous science to deliver everyday health and wellness products. Headquartered in Summit, New Jersey, the company reaches approximately 1.2 billion consumers worldwide across skin health, essential health (pain relief, cold/allergy), and self care categories. Kenvue operates as a public company traded on the NYSE.